Answer
Aug 14, 2025 - 12:12 PM
Retatrutide is a medication that acts as a multi-receptor agonist, targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. It is primarily being investigated for its potential to aid in weight loss and improve metabolic health by enhancing insulin sensitivity, reducing appetite, and promoting energy expenditure. This combination of effects can lead to significant reductions in body weight and improvements in markers of metabolic health.
